Trauma Hemostasis and Oxygenation Research Network position paper on the role of hypotensive resuscitation as part of remote damage control resuscitation by Woolley, Thomas et al.
Trauma Hemostasis and Oxygenation
Research Network position paper on the
role of hypotensive resuscitation as part of
remote damage control resuscitation
Woolley, Thomas, MD; Thompson, Patrick; Kirkman, Emrys, PhD; Reed, Richard; Ausset, Sylvain, MD; Beckett,
Andrew, MD; Bjerkvig, Christopher, MD; Cap, Andrew, P., MD, PhD; Coats, Tim, MD; Cohen, Mitchell, MD;
Despasquale, Marc; Dorlac, Warren, MD; Doughty, Heidi; Dutton, Richard, MD; Eastridge, Brian; Glassberg,
Elon, MD; Hudson, Anthony; Jenkins, Donald, MD; Keenan, Sean, MD; Martinaud, Christophe, PhD; Miles,
Ethan; Moore, Ernest, MD; Nordmann, Giles; Prat, Nicolas, PhD; Rappold, Joseph, MD; Reade, Michael, C.,
MBBD D Phil; Rees, Paul, MD; Rickard, Rory, PhD; Schreiber, Martin, MD; Shackelford, Stacy, MD; Skogran
Eliassen, Håkon; Smith, Jason, MD; Smith, Mike, PhD; Spinella, Philip, MD; Strandenes, Geir, MD; Ward,
Kevin, MD; Watts, Sarah, PhD; White, Nathan, MD; Williams, Steve
Journal of Trauma and Acute Care Surgery: June 2018 - Volume 84 - Issue 6S - p S3–S13
doi: 10.1097/TA.0000000000001856
Thor 2018
ABSTRACT The Trauma Hemostasis and Oxygenation Research (THOR) Network has developed a consensus
statement on the role of permissive hypotension in remote damage control resuscitation (RDCR). A summary of
the evidence on permissive hypotension follows the THOR Network position on the topic. In RDCR, the burden
of time in the care of the patients suffering from noncompressible hemorrhage affects outcomes. Despite the lack
of published evidence, and based on clinical experience and expertise, it is the THOR Network’s opinion that the
increase in prehospital time leads to an increased burden of shock, which poses a greater risk to the patient than
the risk of rebleeding due to slightly increased blood pressure, especially when blood products are available as
part of prehospital resuscitation.
The THOR Network’s consensus statement is, “In a casualty with life-threatening hemorrhage, shock should be
reversed as soon as possible using a blood-based HR fluid. Whole blood is preferred to blood components. As a
part of this HR, the initial systolic blood pressure target should be 100 mm Hg. In RDCR, it is vital for higher
echelon care providers to receive a casualty with sufficient physiologic reserve to survive definitive surgical
hemostasis and aggressive resuscitation. The combined use of blood-based resuscitation and limiting systolic
blood pressure is believed to be effective in promoting hemostasis and reversing shock”
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